Cara Therapeutics
biotechnology company
Based in CT
🤖
AI Overview
With $237K in lobbying spend across 26 quarterly filings, Cara Therapeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2024.
$237K
Total Spend
7
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $27K |
| 2019 | $38K |
| 2020 | $23K |
| 2021 | $62K |
| 2022 | $27K |
| 2023 | $60K |
| 2024 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid
- •ESRD CY 2019 Prospective Payment System Proposed and Final Rules
- •ESRD PPS CY 2019 Proposed Rule
- •ESRD PPS CY 2019 Proposed and Final Rule
- •Implementation of the ESRD prospective payment system and proposed rule
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.